A 2017 meta-analysis of 142 studies of presynaptic DAT and SPECT imaging in PD found that across all ligands, the greatest reduction in uptake was observed in the putamen, particularly in posterior regions. The gene discussed is SLC6A3; the disease is Parkinson disease.